Adagio Medical Holdings, Inc. Price & Performance (ADGM)

Adagio Medical Holdings, Inc. experienced a 3.47% decline on March 25, closing at $0.79. The stock fluctuated significantly, with a 10.40% movement between its daily high and low. Despite a weak short-term rising trend, technical indicators suggest the stock remains high-risk, with limited positive signals for the near future.12

John Dahldorf, CFO of Adagio Medical, officially stepped down on March 21, 2025. The resignation comes as the company navigates critical clinical trials for its VT Cryoablation System. While the company emphasizes progress in trials, the leadership transition raises questions about financial stability during this pivotal period.34

Supira Medical announced it raised $120 million in an oversubscribed Series E round, marking a significant milestone. The funding will support its early feasibility study in the U.S. for heart failure treatments. This development highlights investor interest in innovative medical technologies poised for regulatory approval.5